Lb Pharmaceuticals (LBRX) Other Accumulated Expenses (2024 - 2026)

Lb Pharmaceuticals' Other Accumulated Expenses history runs 3 years deep, the most recent figure standing at $132000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses changed N/A year-over-year to $132000.0; the TTM figure through Mar 2026 stood at $132000.0 (changed N/A YoY), while the FY2025 annual figure was $267000.0, up 17.11% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $132000.0, down from $267000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $267000.0 in Q4 2025, with the low at $101000.0 in Q3 2025.
• The 3-year median for Other Accumulated Expenses is $180000.0 (2024), against an average of $182000.0.
• Peak annual rise in Other Accumulated Expenses reached 17.11% in 2025, while the deepest fall reached 17.11% in 2025.
• Lb Pharmaceuticals' Other Accumulated Expenses stood at $228000.0 in 2024, then rose by 17.11% to $267000.0 in 2025, then slumped by 50.56% to $132000.0 in 2026.
• Business Quant data shows LBRX's Other Accumulated Expenses at $132000.0 in Q1 2026, $267000.0 in Q4 2025, and $101000.0 in Q3 2025.